Otte A - Search Results

1

Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.

Vermeersch H, Loose D, Ham H, Otte A, Van de Wiele C. Vermeersch H, et al. Among authors: otte a. Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1689-700. doi: 10.1007/s00259-003-1345-4. Epub 2003 Oct 22. Eur J Nucl Med Mol Imaging. 2003. PMID: 14574516 Review.

2

Renal toxicity after radionuclide therapy.

Lambert B, Cybulla M, Weiner SM, Van De Wiele C, Ham H, Dierckx RA, Otte A. Lambert B, et al. Among authors: otte a. Radiat Res. 2004 May;161(5):607-11. doi: 10.1667/rr3105. Radiat Res. 2004. PMID: 15161361 Review.

3

Cognitive neuroactivation using SPECT and the Stroop Colored Word Test in patients with diffuse brain injury.

Goethals I, Audenaert K, Jacobs F, Lannoo E, Van de Wiele C, Ham H, Otte A, Oostra K, Dierckx R. Goethals I, et al. Among authors: otte a. J Neurotrauma. 2004 Aug;21(8):1059-69. doi: 10.1089/0897715041651051. J Neurotrauma. 2004. PMID: 15319005

4

Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next step.

Otte A, van de Wiele C, Dierckx RA. Otte A, et al. Nucl Med Commun. 2009 Jan;30(1):5-15. doi: 10.1097/MNM.0b013e328313e565. Nucl Med Commun. 2009. PMID: 19020470 Review.

5

The exceptional brain of Maurice Ravel.

Otte A, De Bondt P, Van De Wiele C, Audenaert K, Dierckx R. Otte A, et al. Med Sci Monit. 2003 Jun;9(6):RA134-9. Med Sci Monit. 2003. PMID: 12824964

6

The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measured with 123I-5-I-R91150 SPECT.

Peremans K, Audenaert K, Hoybergs Y, Otte A, Goethals I, Gielen I, Blankaert P, Vervaet M, van Heeringen C, Dierckx R. Peremans K, et al. Among authors: otte a. Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):708-16. doi: 10.1007/s00259-005-1772-5. Eur J Nucl Med Mol Imaging. 2005. PMID: 15739093

7

Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150.

Peremans K, Audenaert K, Coopman F, Blanckaert P, Jacobs F, Otte A, Verschooten F, van Bree H, van Heeringen K, Mertens J, Slegers G, Dierckx R. Peremans K, et al. Among authors: otte a. Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1538-46. doi: 10.1007/s00259-003-1250-x. Epub 2003 Jul 3. Eur J Nucl Med Mol Imaging. 2003. PMID: 14579095

8

Soft tissue metastasis of an osteosarcoma of the humerus in a four-legged patient.

Peremans K, Otte A, Verschooten F, Van Bree H, Dierckx R. Peremans K, et al. Among authors: otte a. Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):188. doi: 10.1007/s00259-002-1041-9. Epub 2002 Nov 16. Eur J Nucl Med Mol Imaging. 2003. PMID: 12483426 No abstract available.

9

Good clinical practice: a plea for nuclear medicine.

Otte A, Dierckx RA. Otte A, et al. Nucl Med Commun. 2005 Jul;26(7):561. doi: 10.1097/01.mnm.0000169203.75635.ad. Nucl Med Commun. 2005. PMID: 15942474 No abstract available.

10

Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis?

Nitzsche EU, Hoegerle S, Mix M, Brink I, Otte A, Moser E, Imdahl A. Nitzsche EU, et al. Among authors: otte a. Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):237-42. doi: 10.1007/s00259-001-0697-x. Eur J Nucl Med Mol Imaging. 2002. PMID: 11926386

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters